Bio-Techne Corp TECH

NASDAQ US Health Care Life Sciences Tools & Services

$72.61 ▲ +0.06% (+$0.04)

Index member: S&P 500

Open $72.59

Prev Close $72.57

Day Range $72.56 – $72.64

52W Range $43.20 – $72.69

Market Cap $11.38B

P/E (TTM) 62.59

Beta 1.30

Div Yield 0.50%

EPS (TTM) $1.16

📋 Company Profile

Industry	Life Sciences Tools & Services
Sector	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	1989-02-09
Shares Out.	155,810,000
Website	bio-techne.com/ ↗
Phone	16123798854
Employees	3,000
Revenue	$321.2M
Gross Profit	$211.4M
Net Income	$54.6M
Free Cash Flow	$263.2M
Total Assets	$2.59B
Total Liabilities	$478.5M
Equity	$2.11B

About Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Bio-Techne Corp is a publicly traded company under the ticker symbol TECH on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.